Winoah Henry, MD
Gastroenterology · Lewiston, MENPI 1043456049
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (34.3%), speaking fees and food and beverage — rather than concentrated in one kind of arrangement. 12 manufacturers reported payments, led by Gilead at 53.6% of the total. 2025 is the largest year on record at $11,113, more than ten times the $291 reported in 2022.
Across 112 payments — averaging $113.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Gilead$7K
- Ipsen Biopharmaceuticals, Inc$4K
- AbbVie$1K
- Madrigal Pharmaceuticals$327
- Johnson & Johnson$239
- Boston Scientific$170
- plus $385 from 6 others
What the payments were for
- Consulting fees$4,37034%
- Speaking & faculty fees$3,52828%
- Travel & lodging$1,54012%
- Food & beverage$3,26326%
- Education$220%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Gilead | 26 | $6,821 |
| Ipsen Biopharmaceuticals, Inc | 6 | $3,636 |
| AbbVie | 47 | $1,146 |
| Madrigal Pharmaceuticals | 6 | $327 |
| Johnson & Johnson | 8 | $239 |
| Boston Scientific | 2 | $170 |
| Sanofi | 3 | $138 |
| Merck | 5 | $89 |
| Bristol Myers Squibb | 5 | $80 |
| Regeneron Healthcare Solutions, Inc. | 2 | $42 |
| Ferring Pharmaceuticals Inc. | 1 | $20 |
| Lucid Diagnostics Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$12,723 in reported general payments places this provider in the 85th percentile of 68 gastroenterology providers in Maine.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dupixent PenDupilumab | 13 | $97,181 |
| XifaxanRifaximin | 16 | $53,640 |
| Mesalamine | 16 | $10,959 |
| Ursodiol | 23 | $4,026 |
| Lubiprostone | 16 | $3,873 |
| Budesonide DrBudesonide | 19 | $3,619 |
| Peg 3350-ElectrolyteSodium Chloride/Nahco3/Kcl/Peg | 158 | $2,914 |
| Sod Sulf-Potass Sulf-Mag SulfSodium, Potassium,mag Sulfates | 46 | $2,574 |
| Pantoprazole Sodium | 145 | $2,453 |
| Sucralfate | 42 | $1,497 |
| Omeprazole | 22 | $574 |
| Lactulose | 28 | $558 |
| Gavilyte-GPeg3350/Sod Sulf,bicarb,cl/Kcl | 45 | $555 |
| Spironolactone | 36 | $459 |
| Gavilyte-NSodium Chloride/Nahco3/Kcl/Peg | 35 | $448 |
Paid to pharmacies, not to this prescriber.
Other gastroenterology in Lewiston
- Benjamin SteinLewiston$4K
- Oswaldo BisbalLewiston$2K
- Emil MiskovskyLewiston$2K
- John MladuckyLewiston$2K
- John LewandowskiLewiston$250
- Catherine McCrannLewiston$146
- Douglas HowellPortland$1.2M
- Martin MoehlenPortland$340K
- Tahira SaifuddinBangor$84K
- Brian BerberianBangor$70K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.